Consumption of morphine equivalents 0 to 24 hmg · patients with postoperative pain
1 finding from 1 review
Consumption of morphine equivalents 25 to 48 hmg · patients with postoperative pain
1 finding from 1 review
Consumption of morphine equivalents 0 to 48 hmg · patients with postoperative pain
1 finding from 1 review
Consumption of morphine equivalents 0 to 72 hmg · patients with postoperative pain
1 finding from 1 review
Daily mean opiate intake per hour · People with cancer receiving chemotherapy or radiotherapy (or both) who have oral mucositis
Morphine via patient-controlled analgesia (PCA) led to lower daily mean opiate intake per hour compared with morphine via continuous infusion (CI); GRADE not reported.
1 finding from 1 review
Average pain scores (0-100 VAS) · People with cancer receiving chemotherapy or radiotherapy (or both) who have oral mucositis
Morphine via patient-controlled analgesia (PCA) showed no clear difference in average pain scores (0-100 VAS) compared with morphine via continuous infusion (CI); GRADE not reported.
1 finding from 1 review
Duration of pain control therapy (days) · People with cancer receiving chemotherapy or radiotherapy (or both) who have oral mucositis
Morphine via patient-controlled analgesia (PCA) led to lower duration of pain control therapy (days) compared with morphine via continuous infusion (CI); GRADE not reported.
1 finding from 1 review
Daily mean opiate intake per hour · People with cancer receiving chemotherapy or radiotherapy (or both) who have oral mucositis
Morphine via pharmacokinetically based PCA (PKPCA) led to higher daily mean opiate intake per hour compared with morphine via patient-controlled analgesia (PCA); GRADE not reported.
1 finding from 1 review
Average pain scores (0-100 VAS) · People with cancer receiving chemotherapy or radiotherapy (or both) who have oral mucositis
Morphine via pharmacokinetically based PCA (PKPCA) led to lower average pain scores (0-100 VAS) compared with morphine via patient-controlled analgesia (PCA); GRADE not reported.
1 finding from 1 review
Intraperitoneal pain (NRS; higher = more pain) · women undergoing PPTL under local anaesthesia
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Adverse events within 48 hours post operation · women undergoing PPTL under local anaesthesia
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Number of women requiring rescue medication · women undergoing PPTL under local anaesthesia
Combination of lidocaine intraperitoneal instillation plus… may leads to lower number of women requiring rescue medication compared with intramuscular morphine alone (low certainty).
1 finding from 1 review
RR 0.11 [0.03, 0.42]
Studies not reported
Low
Intervention not reported
Day 1 morphine · Laparoscopic abdominal surgery (morphine consumption)
1 finding from 1 review
Intervention not reported
Day 1 morphine: heated, humidified vs cold · Laparoscopic abdominal surgery (morphine consumption)
1 finding from 1 review
Intervention not reported
Day 1 morphine: heated only vs cold · Laparoscopic abdominal surgery (morphine consumption)
1 finding from 1 review
Intervention not reported
Day 2 morphine · Laparoscopic abdominal surgery (morphine consumption)
1 finding from 1 review
Intervention not reported
Day 2 morphine: heated, humidified vs cold · Laparoscopic abdominal surgery (morphine consumption)
1 finding from 1 review
Intervention not reported
Day 2 morphine: heated only vs cold · Laparoscopic abdominal surgery (morphine consumption)
1 finding from 1 review
Intraperitoneal pain (NRS; higher = more pain) · women undergoing PPTL under local anaesthesia
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Adverse events within 48 hours post operation · women undergoing PPTL under local anaesthesia
1 finding from 1 review
no estimate extracted
Studies not reported
Very low